Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Gujarat Inject (Kerala) Ltd. Share Price
Day's Range
Low
₹
High
₹
Price Summary
| Previous Close | ₹9.35 |
|---|---|
| Day's Range | ₹9.20 - ₹9.50 |
| Open | ₹9.50 |
| 52 Week Range | ₹01.95 - ₹14.30 |
| Volume | 3,54,344 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 33.42 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 45.76 |
| TTM EPS (₹) | 0.20 |
| P/E Ratio | 135.74 |
| Book Value(₹) | 10.46 |
| PAT Margin (%) | 1.43 |
| Face Value (₹) | 1.00 |
| ROCE(%) | 2.54 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 24.21 | 190.46 |
| Expenses | N/A | N/A |
| PBT | 0.98 | 12.54 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 0.74 | 10.17 |
About Gujarat Inject (Kerala) Ltd.
| Founded | 1991 |
|---|
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,41,477.63 | 1,840.00 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 2,53,031.38 | 9,531.50 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,85,216.32 | 4,869.40 | 3,480.60 - 3,480.60 |
| Apollo Hospitals Enterprise Ltd. | 1,27,421.96 | 8,862.00 | 6,696.50 - 6,696.50 |
| Zydus Lifesciences Ltd. | 1,20,897.46 | 1,212.00 | 835.50 - 835.50 |
| Lenskart Solutions Ltd. | 1,14,028.91 | 655.60 | 0.00 - 0.00 |
| Cipla Ltd. | 1,12,205.15 | 1,388.90 | 1,165.70 - 1,165.70 |
| Laurus Labs Ltd. | 1,08,710.82 | 2,012.00 | 823.10 - 823.10 |
| Dr. Reddy's Laboratories Ltd. | 1,02,039.66 | 1,222.50 | 1,101.00 - 1,101.00 |
| Mankind Pharma Ltd. | 1,00,764.41 | 2,439.55 | 1,909.70 - 1,909.70 |
No Records Found
Latest News
Gujarat Inject Kerala informs about outcome of board meeting
Pursuant to Regulations 30, 33 and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Gujarat Inject Kerala has informed that the Board of Directors of the Company at its meeting held today Wednesday, 15th July, 2026 has discussed, approved, and taken on record the following matter: 1. Approved Un-Audited Financial Results of the Company for the First Quarter ended on 30th June, 2026; and 2. took on record ‘Limited Review Report’ thereon issued by S Mandawat & Co., Statutory Auditors of the Company. A copy of the approved Un-Audited Financial Results along with Limited Review Report are enclosed. The meeting commenced at 09:00 am and concluded at 09:45 am at the Registered Office of the Company.
The above information is a part of company’s filings submitted to BSE.
Gujarat Inject Kerala informs about board meeting
Gujarat Inject Kerala has informed that the meeting of the Board of Directors of the Company is scheduled on 15/07/2026, inter alia, to consider and approve consideration and approval of financial results.
The above information is a part of company’s filings submitted to BSE.
Aarti Pharmalabs informs about closure of trading window
Pursuant to Company’s Code Prohibition of Insider Trading framed pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and amendments thereunder, Aarti Pharmalabs has informed that the trading window for dealing in the securities of the Company will remain closed from Thursday, October 01, 2026 till 48 hours after the declaration of Financial Results of the Company for the quarter ending on September 30, 2026. The same has also been intimated to all the Designated Persons/Connected Persons of the Company. The date of the Board Meeting in which the said results will be considered for approval, will be informed in due course.
The above information is a part of company’s filings submitted to BSE.
Morepen Laboratories informs about press release
Lupin informs about press release
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Gujarat Inject (Kerala) Ltd. is ₹9.35 as of 2026-09-28.
The market capitalisation of Gujarat Inject (Kerala) Ltd. is ₹136.97 as of 2026-09-28.
The 1-year return of Gujarat Inject (Kerala) Ltd. is 7.34% as of 2026-09-28.
The P/E ratio of Gujarat Inject (Kerala) Ltd. is 135.74 as of 2026-09-29.
The 52-week high and low of Gujarat Inject (Kerala) Ltd. are ₹14.30 and ₹1.95, respectively, as of 2026-09-28.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
